Compare Summit Therapeutics Inc (SMMT) vs Tractor Supply Co (TSCO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Summit Therapeutics Inc vs Tractor Supply Co — how do they compare? Summit Therapeutics Inc trades at $17.52 (market cap $13.79B), while Tractor Supply Co trades at $34 (market cap $18.39B). The key difference: Tractor Supply Co is the larger of the two by market cap, and Tractor Supply Co pays a 2.72% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.
| SMMT | TSCO | |
|---|---|---|
Market Cap | $13.79B | $18.39B |
Sector | Health | Consumer Cyclical |
52-Week High | $26.38 | $60.61 |
52-Week Low | $12.43 | $29.14 |
Enterprise Value | $13.11B | $24.70B |
Dividend Yield | — | 2.72% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Summit Therapeutics (SMMT) trades at $17.28, down 1.85% on the day, with a bullish technical signal from moving averages but overbought RSI readings. The company reported a net loss of $1.08 billion for 2025, negative ROE of -192.5%, and relies on financing cash flow for liquidity. Recent news highlights positive Phase III trial results for ivonescimab in lung and biliary tract cancers, driving investor optimism ahead of a key FDA decision in November 2026.
The outlook hinges on regulatory approval and commercial success of ivonescimab, with a consensus price target of $25.23 implying 46% upside. Risks include high cash burn, clinical trial uncertainties, and potential dilution from financing activities. Analyst sentiment is bullish (60.9% buy ratings), but the stock remains speculative due to its pre-revenue status and dependence on pipeline milestones.
Tractor Supply Company (TSCO) trades at $35.29, up 0.86% on the day, with a bullish technical signal from moving averages. The stock is supported by strong profitability, including a 39.51% ROE and 6.42% net income margin, though recent quarterly EPS results have missed expectations. Revenue growth remains steady, reaching $15.52B in 2025, while analyst consensus is a Buy with a $36.29 price target. Recent corporate developments include a dividend payment and participation in industry conferences.
The outlook for TSCO is cautiously optimistic, with upside potential near the consensus target, but risks include competitive pressures and cyclical sales headwinds. Investment appeal hinges on execution of strategic initiatives in pet care and logistics, while monitoring margin trends and same-store sales performance is critical for sustained growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →About Tractor Supply Co
Tractor Supply is the largest operator of retail farm and ranch stores in the United States. The company targets recreational farmers and ranchers and has little exposure to commercial and industrial farm operations. Currently, the company operates 2,016 of its namesake banners in 49 states and 178 Petsense stores. Stores are typically located in towns outside of urban areas and in rural communities. In fiscal 2021, revenue consisted primarily of livestock and pet (47%), hardware, tools, and truck (21%), and seasonal gift and toy (21%).
Read more on TSCO →
